154 related articles for article (PubMed ID: 11399108)
21. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
[TBL] [Abstract][Full Text] [Related]
22. [Partial trisomy 21].
Mattéi JF; Mattéi MG; Ardissone JP; Charvet JP; Chiaramello W; Giraud F
Arch Fr Pediatr; 1979 Apr; 36(4):404-12. PubMed ID: 159024
[TBL] [Abstract][Full Text] [Related]
23. Down's syndrome astrocytes have greater antioxidant capacity than euploid astrocytes.
Sebastià J; Cristòfol R; Pertusa M; Vílchez D; Torán N; Barambio S; Rodríguez-Farré E; Sanfeliu C
Eur J Neurosci; 2004 Nov; 20(9):2355-66. PubMed ID: 15525277
[TBL] [Abstract][Full Text] [Related]
24. Neuronal-specific expression of human copper-zinc superoxide dismutase gene in transgenic mice: animal model of gene dosage effects in Down's syndrome.
Ceballos-Picot I; Nicole A; Briand P; Grimber G; Delacourte A; Defossez A; Javoy-Agid F; Lafon M; Blouin JL; Sinet PM
Brain Res; 1991 Jun; 552(2):198-214. PubMed ID: 1717112
[TBL] [Abstract][Full Text] [Related]
25. Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain.
Brooksbank BW; Balazs R
Brain Res; 1984 Sep; 318(1):37-44. PubMed ID: 6237715
[TBL] [Abstract][Full Text] [Related]
26. Antioxidant system in Down syndrome: a possible role in cataractogenesis.
Cengiz M; Seven M; Suyugül N
Genet Couns; 2002; 13(3):339-42. PubMed ID: 12416643
[TBL] [Abstract][Full Text] [Related]
27. [Breast cancer in women with trisomy 21].
Satgé D; Sasco AJ; Pujol H; Rethoré MO
Bull Acad Natl Med; 2001; 185(7):1239-52; discussion 1252-4. PubMed ID: 11975321
[TBL] [Abstract][Full Text] [Related]
28. Cu/Zn superoxide dismutase in patients with non-familial Alzheimer's disease.
Margaglione M; Garofano R; Cirillo F; Ruocco A; Grandone E; Vecchione G; Milan G; Di Minno G; De Blasi A; Postiglione A
Aging (Milano); 1995 Feb; 7(1):49-54. PubMed ID: 7599248
[TBL] [Abstract][Full Text] [Related]
29. Human carbonyl reductase (CBR) localized to band 21q22.1 by high-resolution fluorescence in situ hybridization displays gene dosage effects in trisomy 21 cells.
Lemieux N; Malfoy B; Forrest GL
Genomics; 1993 Jan; 15(1):169-72. PubMed ID: 8432528
[TBL] [Abstract][Full Text] [Related]
30. Down's syndrome phenotype and autosomal gene inactivation in a child with presumed (X;21) de novo translocation.
Taysi K; Sparkes RS; O'Brien TJ; Dengler DR
J Med Genet; 1982 Apr; 19(2):144-8. PubMed ID: 6210775
[TBL] [Abstract][Full Text] [Related]
31. Down syndrome with duplication of a region of chromosome 21 containing the CuZn superoxide dismutase gene without detectable karyotypic abnormality.
Huret JL; Delabar JM; Marlhens F; Aurias A; Nicole A; Berthier M; Tanzer J; Sinet PM
Hum Genet; 1987 Mar; 75(3):251-7. PubMed ID: 2951317
[TBL] [Abstract][Full Text] [Related]
32. Superoxide dismutase--applications and relevance to human diseases.
Noor R; Mittal S; Iqbal J
Med Sci Monit; 2002 Sep; 8(9):RA210-5. PubMed ID: 12218958
[TBL] [Abstract][Full Text] [Related]
33. [From the information on a structural gene to the disease].
Smarda J
Cas Lek Cesk; 1995 Jan; 134(1):7-12. PubMed ID: 7712522
[TBL] [Abstract][Full Text] [Related]
34. [Neurological complications in Down's Syndrome].
Lev N; Melamed E
Harefuah; 2002 Sep; 141(9):820-3, 857. PubMed ID: 12362489
[TBL] [Abstract][Full Text] [Related]
35. Ets-2 is induced by oxidative stress and sensitizes cells to H(2)O(2)-induced apoptosis: implications for Down's syndrome.
Sanij E; Hatzistavrou T; Hertzog P; Kola I; Wolvetang EJ
Biochem Biophys Res Commun; 2001 Oct; 287(4):1003-8. PubMed ID: 11573964
[TBL] [Abstract][Full Text] [Related]
36. Proliferation deficits and gene expression dysregulation in Down's syndrome (Ts1Cje) neural progenitor cells cultured from neurospheres.
Moldrich RX; Dauphinot L; Laffaire J; Vitalis T; Hérault Y; Beart PM; Rossier J; Vivien D; Gehrig C; Antonarakis SE; Lyle R; Potier MC
J Neurosci Res; 2009 Nov; 87(14):3143-52. PubMed ID: 19472221
[TBL] [Abstract][Full Text] [Related]
37. Islet autoimmunity in children with Down's syndrome.
Gillespie KM; Dix RJ; Williams AJ; Newton R; Robinson ZF; Bingley PJ; Gale EA; Shield JP
Diabetes; 2006 Nov; 55(11):3185-8. PubMed ID: 17065360
[TBL] [Abstract][Full Text] [Related]
38. Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down's syndrome.
Tórsdóttir G; Kristinsson J; Hreidarsson S; Snaedal J; Jóhannesson T
Pharmacol Toxicol; 2001 Dec; 89(6):320-5. PubMed ID: 11903959
[TBL] [Abstract][Full Text] [Related]
39. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
[TBL] [Abstract][Full Text] [Related]
40. Early thymic T cell development in young transgenic mice overexpressing human Cu/Zn superoxide dismutase, a model of Down syndrome.
Laurent J; Paly E; Marche PN; London J
Free Radic Biol Med; 2006 Jun; 40(11):1971-80. PubMed ID: 16716898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
